Subhayan Mayra Erstellt neuen Artikel
4 w

Global Prophylactic HIV Drug Market Growing at 7.8% CAGR Through 2034 | #prophylactic HIV Drug # PrEP # HIV Prevention # Pre-Exposure Prophylaxis # Post-Exposure Prophylaxis # Antiretroviral # Integrase Inhibitor # Truvada # Descovy # HIV/AIDS

Global Prophylactic HIV Drug Market Growing at 7.8% CAGR Through 2034

Global Prophylactic HIV Drug Market Growing at 7.8% CAGR Through 2034

Global Prophylactic HIV Drug Market valued at USD 3.45 billion in 2025 is projected to reach USD 6.12 billion by 2034, growing at 7.8% CAGR. Increasing global HIV prevalence, advancements in drug formulations, and government initiatives drive growth. North America leads with high PrEP adop